Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?: An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

European Journal of Cancer

Volumn 47, Issue 1, 2011, Pages 57-64

  Verleye, Leen ^a   Ottevanger, Petronella B ^b   Kristensen, Gunnar B ^c   Ehlen, Tom ^d   Johnson, Nick ^e   Van Der Burg, Maria E L ^f   Reed, Nick S ^g   Verheijen, René H M ^h   Gaarenstroom, Katja N ⁱ   Mosgaard, Berit ^j   Seoane, Jose M ^k   Van Der Velden, Jacobus ^l   Lotocki, Robert ^m   Van Der Graaf, Winette ^b   Penninckx, Björn ^a   Coens, Corneel ^a   Stuart, Gavin ^d   Vergote, Ignace ⁿ  

^a EORTC DATA CENTER   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e ROYAL UNITED HOSPITAL   (United Kingdom)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^k HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m CANCERCARE MANITOBA   (Canada)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

Ovarian cancer; Quality of health care; Surgical pathology

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE TUBE CARCINOMA;

DATA COLLECTION; FEMALE; HEALTH FACILITY SIZE; HUMANS; MEDICAL AUDIT; MEDICAL RECORDS; OVARIAN NEOPLASMS; PATHOLOGY, CLINICAL; QUALITY ASSURANCE, HEALTH CARE;

EID: 78650417438     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.08.008     Document Type: Article

References (44)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. F. Berrino, A.R. De, and M. Sant Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study Lancet Oncol 8 2007 773 783
3. Institute of Medicine. Medicare - a strategy for quality assurance. Washington (DC): National Academy Press; 1999.
4. R.E. Nakhleh Core components of a comprehensive quality assurance program in anatomic pathology Adv Anat Pathol 16 2009 418 423
5. I. Vergote, C. Trope, and F. Amant Neoadjuvant chemotherapy or primary surgery in stage IIIc-IV ovarian cancer N Engl J Med 363 2010 943 953
6. A.R. Gagliardi, M.F. Fung, B. Langer, H. Stern, and A.D. Brown Development of ovarian cancer surgery quality indicators using a modified Delphi approach Gynecol Oncol 97 2005 446 456 (Pubitemid 40614889)
7. S.J. Robboy, F.T. Kraus, and R.J. Kurman Gross description, processing and reporting of gynecologic and obstetric specimens R.J. Kurman, Blaustein's pathology of the female genital tract 2002 Springer-Verlag New York, Berlin, Heidelberg 1319 1345
8. R.E. Scully, D.E. Henson, M.L. Nielsen, and S.G. Ruby Practice protocol for the examination of specimens removed from patients with ovarian tumors: a basis for checklists. Cancer Committee, College of American Pathologists Gynecol Oncol 63 1996 276 289
9. F. Campbell, and D.F. Griffiths Quantitative audit of the content of histopathology reports J Clin Pathol 47 1994 360 361
10. R. Austin, B. Thompson, and M. Coory Histopathology reporting of breast cancer in Queensland: the impact on the quality of reporting as a result of the introduction of recommendations Pathology 41 2009 361 365
11. B. King, and J. Corry Pathology reporting in head and neck cancer - snapshot of current status Head Neck 31 2009 227 231
12. I.D. Nagtegaal, E.K. Kranenbarg, J. Hermans, V. van d, and J.H. van Krieken Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers J Clin Oncol 18 2000 1771 1779
13. S.K. Apple Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue Breast J 12 2006 145 149
14. FIGO Committee on Gynecologic Oncology. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009;105:3-4.
15. J.D. Bloss, S.Y. Liao, and R.E. Buller Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary Gynecol Oncol 50 1993 347 351
16. J.D. Seidman, R.J. Kurman, and B.M. Ronnett Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis Am J Surg Pathol 27 2003 985 993
17. W.R. Hart Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms Pathol Int 55 2005 231 243
18. I. Vandenput, C.B. Van, and A. Capoen Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Br J Cancer 101 2009 244 249
19. S.J. Ramus, K. Elmasry, and Z. Luo Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer Clin Cancer Res 14 2008 5840 5848
20. W.G. McCluggage, and R.H. Young Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors Semin Diagn Pathol 22 2005 3 32
21. S.M. Powsner, J. Costa, and R.J. Homer Clinicians are from Mars and pathologists are from Venus Arch Pathol Lab Med 124 2000 1040 1046
22. S. Kommoss, D. Schmidt, and F. Kommoss Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol) Virchows Arch 454 2009 249 256
23. W.G. McCluggage, R.W. Lyness, and R.J. Atkinson Morphological effects of chemotherapy on ovarian carcinoma J Clin Pathol 55 2002 27 31
24. T. Le, K. Williams, and M. Senterman Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking Gynecol Oncol 106 2007 160 163 (Pubitemid 46898585)
25. S. Sassen, B. Schmalfeldt, and N. Avril Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer Hum Pathol 38 2007 926 934
26. F. Chang, H. Deere, U. Mahadeva, and S. George Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues Am J Clin Pathol 129 2008 252 262
27. I. Chew, R.A. Soslow, and K.J. Park Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma Int J Gynecol Pathol 28 2009 442 446
28. K. Miller, J.H. Price, and S.P. Dobbs An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma J Clin Pathol 61 2008 652 657
29. S. Nofech-Mozes, M.A. Khalifa, and N. Ismiil Immunophenotyping of serous carcinoma of the female genital tract Mod Pathol 21 2008 1147 1155
30. M.A. Khalifa, J. Dodge, A. Covens, R. Osborne, and I. Ackerman Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy Gynecol Oncol 90 2003 425 430
31. M.D. Cabana, C.S. Rand, and N.R. Powe Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
32. The Royal college of Pathologists. Datasets for the histopathological reporting of neoplasms of the ovaries and fallopian tubes and primary carcinomas of the peritoneum. ; 2008.
33. S. Chafe, L. Honore, R. Pearcey, and V. Capstick An analysis of the impact of pathology review in gynecologic cancer Int J Radiat Oncol Biol Phys 48 2000 1433 1438
34. L. Verleye, P.B. Ottevanger, and I. Vergote Surgical program building in advanced ovarian cancer: European perspective Gynecol Oncol 114 2009 S10 S14
35. H.M. McBroom, and A.D. Ramsay The clinicopathological meeting. A means of auditing diagnostic performance Am J Surg Pathol 17 1993 75 80
36. A.D. Ramsay Errors in histopathology reporting: detection and avoidance Histopathology 34 1999 481 490
37. J.R. Srigley, T. McGowan, and A. Maclean Standardized synoptic cancer pathology reporting: a population-based approach J Surg Oncol 99 2009 517 524
38. L.K. Branston, S. Greening, and R.G. Newcombe The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology Eur J Cancer 38 2002 764 772
39. R.Z. Karim, K.S. van den Berg, and M.H. Colman The advantage of using a synoptic pathology report format for cutaneous melanoma Histopathology 52 2008 130 138
40. W.A. Reid, A.I. al-Nafussi, G. Rebello, and A.R. Williams Effect of using templates on the information included in histopathology reports on specimens of uterine cervix taken by loop excision of the transformation zone J Clin Pathol 52 1999 825 828
41. C.C. Compton Surgical pathology for the oncology patient in the age of standardization: of margins, micrometastasis, and molecular markers Semin Radiat Oncol 13 2003 382 388
42. Association of Directors of Anatomic And Surgical Pathology, Nakhleh R, Coffin C, Cooper K. Recommendations for quality assurance and improvement in surgical and autopsy pathology. Hum Pathol 2006;37:985-988.
43. T.H. van der Kwast, L. Collette, and P.H. Van Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911) Virchows Arch 449 2006 428 434
44. A. Spatz, D.J. Ruiter, C. Busch, I. Theodorovic, and J.W. Oosterhuis The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer Eur J Cancer 38 Suppl. 4 2002 S120 S124